Stoke Therapeutics CMO Sells $457K in Stock Amid 300% Rally

Stoke Therapeutics' chief medical officer, Barry Ticho, sold 14,311 shares of common stock for a transaction value of $457,000 between March 17 and March 19, 2026. This sale represented 26.01% of Ticho's direct common stockholdings, reducing his direct ownership from 55,013 to 40,702 shares. The transaction followed an option exercise with immediate sale and occurred amid a 300% rally in the company's stock price over the past year.